Skip to NavigationSkip to content

UCB's new chief executive picked as EU rep for MISG

Published on: 25/02/15

UCB’s newly-appointed chief executive Jean-Christophe Tellier has been selected to join the Ministerial Industry Strategy Group (MISG).

Elected to the MISG by members of the European Medicines Group (EMG), Tellier will act as group representative for European pharma companies.

Co-chaired by the secretary of state for health and the chairman of the British pharma group, the MISG was set up so government and industry can work together on advancing the bio-pharma environment in the UK, and support research.

On his appointment, Tellier explains: “The UK life sciences industry is one of the most successful at a global level and it is an important contributor to the country’s economic prosperity. Therefore, I am pleased to be sharing some of UCB’s experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Tellier joined UCB in 2011 as an executive vice president, after serving as the president of Ipsen, North America and chief executive of Novartis Pharma France. 

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches